Table 2.
Immunoreactivity of TB MDR patients infected with Haarlem, LAM, and Tuscani Mtb lineages.
| Patient data | Serology2 | |||||||
|---|---|---|---|---|---|---|---|---|
| Code | Sex | Age | SPT family1 | BAAR | Rv2241 | Rv0407 | Rv0009 | Rv2624c |
| MDR18 | F | 24 | Haarlem | + | +++ | +++ | +++ | + |
| MDR5 | F | 35 | Haarlem | − | +++ | ++ | + | ++ |
| MDR19 | M | 28 | Haarlem | +++ | ++ | ++ | ++ | + |
| MDR11 | M | 28 | Haarlem | + | + | +++ | + | + |
| MDR2 | F | 44 | Haarlem | + | + | + | ++ | + |
| MDR3 | F | 47 | Haarlem | + | + | + | ++ | − |
| MDR14 | F | 35 | Haarlem | − | − | + | − | − |
|
| ||||||||
| MDR8 | F | 27 | Tuscani | − | − | − | − | + |
|
| ||||||||
| MDR10 | F | 23 | LAM | + | +++ | +++ | +++ | +++ |
| MDR9 | F | 20 | LAM | − | ++ | ++ | +++ | + |
| MDR6 | M | 49 | LAM | − | − | − | − | − |
| MDR12 | M | 28 | LAM | − | − | − | − | − |
| MDR17 | F | 46 | LAM | +++ | − | − | − | − |
| MDR7 | F | 36 | LAM | + | − | − | − | − |
| MDR13 | M | 24 | LAM | +++ | − | − | − | − |
| MDR4 | F | 40 | LAM | + | − | − | − | − |
| MDR16 | F | 48 | LAM | +++ | − | − | − | − |
| MDR1 | F | 42 | LAM | + | − | − | − | − |
1For each MDR TB patient, genotype of infecting strain was assessed by standard spoligotyping methods [30, 31]. 2The relative OD values among seropositive samples are represented by “+++” (high OD values), “++” (mid OD values) and “+” (low OD values). Seronegative samples are indicated by “−” (OD values below cutoff measure).